The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis

The impact of bacterial overgrowth syndrome and systemic inflammation on abdominal hemodynamics in liver cirrhosis

15.05.2017

Saved in:

Bibliographic Details
Main Authors:	R. V. Maslennikov, M. A. Tatarkina, M. V. Mayevskaya, Ch. S. Pavlov, M. S. Zharkova, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	цирроз печени избыточный бактериальный рост системная воспалительная реакция бактериальная транслокация портальный кровоток мезентериальный кровоток
Online Access:	https://www.gastro-j.ru/jour/article/view/169
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Small intestinal bacterial overgrowth syndrome and systemic inflammation in pathogenesis of hemodynamic changes at liver cirrhosis
by: R. V. Maslennikov, et al.
Published: (2018-08-01)

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency
by: M. V. Mayevskaya, et al.
Published: (2016-08-01)

The effect of Clostridium difficile infection on the course of liver cirrhosis
by: A. A. Driga, et al.
Published: (2018-08-01)

Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Treatment compliance of liver cirrhosis patients
by: Ye. R. Olevskaya, et al.
Published: (2018-08-01)

Liver cirrhosis epidemiology in Chelyabinsk region in 2006-2015
by: A. I. Dolgushina, et al.
Published: (2018-08-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Infusion therapy for chronic liver diseases
by: I. A. Kurkina, et al.
Published: (2018-08-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Principles of diuretic therapy at liver cirrhosis
by: A. I. Dyadyk, et al.
Published: (2018-08-01)

Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers
by: A. F. Sheptulina, et al.
Published: (2016-08-01)

Management of adult patients with alcoholic liver disease: clinical guidelines of the Russian Scientific Liver Society
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

The role of non-alcoholic fatty liver disease in the formation of atherosclerotic vascular lesions in patients with abdominal obesity
by: N. L. Denisov, et al.
Published: (2018-08-01)

Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China
by: M. Ch. Semenistaya, et al.
Published: (2018-08-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
by: I. G. Bakulin, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Primary liver lymphoma: review of the literature and clinical case presentation
by: A. K. Smolyaninova, et al.
Published: (2018-08-01)

Options of dyslipidemia treatment at non-alcoholic fatty liver disease
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Results of non-interventional observational study of ursodeoxycholic acid in primary biliary cirrhosis
by: Yelena N. Shirokova, et al.
Published: (2018-08-01)

Small Intestinal Bacterial Overgrowth in Various Specialties of Medical Practice (Literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2024-05-01)

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01)

Metabolism of bile acids, liver diseases and microbiome
by: Yu. V. Yevsyutina, et al.
Published: (2018-08-01)

Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
by: Е. V. Garanina
Published: (2021-12-01)

Prevalence, Diagnostics and Treatment of Small Intestinal Bacterial Overgrowth in the Clinical Practice in Southern Federal District of the Russian Federation
by: N. V. Korochanskaya, et al.
Published: (2025-02-01)

Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction
by: M. V. Fadeeva, et al.
Published: (2019-06-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Bacterial overgrowth syndrome
by: Yu. A. Kucheryavy, et al.
Published: (2010-11-01)

Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults
by: V. T. Ivashkin, et al.
Published: (2022-09-01)

Recurrent cholestasis in 16 year-old patient (clinical case presentation)
by: I. N. Tikhonov, et al.
Published: (2018-08-01)

Hepatosplenomegaly and severe hypercholesterolemia in 18-year-old female patient
by: M. S. Zharkova, et al.
Published: (2018-08-01)

Small Bowel Bacterial Overgrowth Syndrome in Patients with Bronchial Asthma
by: N. D. Potskhverashvili, et al.
Published: (2018-09-01)

Impact of Novel Coronavirus Infection on the Course and Prognosis of Cirrhosis
by: A. G. Ismailova, et al.
Published: (2024-01-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Hepatic encephalopathy: pathogenesis, clinical presentation, diagnostics, treatment
by: Ch. S. Pavlov, et al.
Published: (2016-08-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19
by: A. V. Nalyotov, et al.
Published: (2022-09-01)

Patient–specific hemodynamic modeling to optimize LVAD speed and right heart health
by: Mustafa M. Ahmed, et al.
Published: (2025-02-01)

Hymecromone Efficacy in the Treatment of Biliary Pancreatitis
by: A. V. Okhlobystin, et al.
Published: (2019-12-01)

Stepwise Improvement of Cerebral Hemodynamics in Staged Angioplasty for Carotid Artery Stenosis
by: Fumiaki OKA, et al.
Published: (2025-01-01)